This journal provides a platform for original research on the effects of psychoactive drugs in both experimental and clinical settings. It bridges the gap between basic science and clinical practice, fostering a deeper understanding of psychopharmacology. The initial part clearly states the journal's area.
It publishes studies on the behavioral, neurochemical, and psychological effects of drugs, as well as clinical trials evaluating the efficacy and safety of psychopharmacological treatments. Key areas of focus include mood disorders, anxiety disorders, schizophrenia, and substance use disorders. The journal emphasizes rigorous methodologies and translational research, promoting the development of new and improved treatments for mental health conditions.
By disseminating cutting-edge findings, the journal contributes to the advancement of psychopharmacology and the improvement of mental healthcare. Researchers and clinicians are encouraged to submit their work, helping to shape the future of this important field.